Insider Transactions in Q4 2024 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Neal Walker INTERIM PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,722
-0.2%
|
$2,722
$1.18 P/Share
|
|
Oct 01
2024
|
Neal Walker INTERIM PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+0.69%
|
-
|